Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 9,732 - -
Change - -44.47% -24.57% -2.31% -10.57% 18.51% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 8,983 8,767 8,626
Change - -47.11% -24.24% -2.91% -9.8% 14.08% -2.41% -1.61%
P/E 5.38x - -14.8x -5.03x 10.9x 43.7x 42.7x 43x
PBR - 1.27x 1.05x 1.41x 1.11x - - -
PEG - - - -0x -0x -0.6x 18.7x -60.99x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.79x 3.71x 3.67x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 3.5x 3.34x 3.25x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 22.7x 21.4x 19.9x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 30.8x 27.1x 25.8x
EV / FCF 41.9x 127x 24x - - 28.6x 29.7x 26x
FCF Yield 2.39% 0.79% 4.17% - - 3.5% 3.36% 3.84%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.32 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,569 2,624 2,654
EBITDA 1 677.5 667.9 535.9 479.5 453.2 395.8 408.8 432.6
EBIT 1 571.2 524 378.9 331.3 311.6 292 324 334.4
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 224.8 229.7 228.3
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 363.73 363.73 363.73
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,738 - -
Announcement Date 10/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
29.81x3.99x15.41x2.52% 176B
19.66x3.56x12.74x3.06% 118B
22x4.32x15.07x1.27% 108B
25.99x2.56x10.26x2.76% 75.34B
17.8x0.21x12.98x0.73% 62.03B
30.51x7.58x19.51x1.31% 52.8B
36.4x3.49x11.96x2.08% 51.45B
35.48x8.82x24.71x-.--% 41.28B
48.26x1.32x12.25x0.2% 31.37B
Average 29.55x 3.98x 14.99x 1.55% 79.61B
Weighted average by Cap. 27.18x 3.88x 14.62x 1.92%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Bio-Rad Laboratories, Inc.

Historical PBR trend

Valuation ratios - PBR - Bio-Rad Laboratories, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Bio-Rad Laboratories, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Bio-Rad Laboratories, Inc.

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. BIO.B Stock
  5. Valuation Bio-Rad Laboratories, Inc.